Delivery Order SPE2DB22D2206-SPE2DB25FHW74
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,965.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets in a 90-count package. Issued on September 18, 2025, with an ultimate completion date of September 19, 2025, this firm fixed-price delivery order represents a non-competitive award under an existing contract vehicle. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Jardiance 10 mg tablets in quantities of 90 units. This competitively awarded contract, valued at $34,528.08, represents a firm fixed-price delivery order with performance completion scheduled for August 28, 2025. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, and carries no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,961.21 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed price delivery order represents a competitively awarded, non-set-aside contract with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Jardiance 10 mg tablets (90-count packages) under a firm fixed-price contract valued at $2,172.69. This non-competitive delivery order is one of many pharmaceutical supply transactions executed through AmerisourceBergen's prime indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle extending through December 2026. The work will be...
- The Defense Logistics Agency awarded a delivery order valued at $22,670.24 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on June 12, 2025, with a completion date of June 13, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and designates AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,130.81 on July 31, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract has an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $37,169.95 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on September 10, 2025, with completion targeted for September 11, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a $11,502.77 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Jardiance 10 mg tablets (90-count package), with a completion date of June 20, 2025. This contract was competitively awarded with no set-aside designation and operates under a firm fixed-price structure. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on August 19, 2025, for supply of Jardiance 10 mg tablets in quantities of 90 units, with a ceiling value of $62,283.78 and firm fixed pricing. This non-set-aside, competitively awarded contract is scheduled for completion by August 20, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order falls under the company's substantial Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,578.57 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is sourced from AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle valued...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FHW74Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,436.38 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Jardiance 10 mg tablets in quantities of 90. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of July 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle valued through December 2026 that enables the company to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver a comprehensive range of pharmaceutical products, medical supplies, and specialized healthcare commodities across multiple therapeutic domains. Through its DLA Troop Support Medical contract, the company supplies medications, vaccines, syringes, and test kits to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The current delivery order for Jardiance, a diabetes medication, reflects the company's ongoing role in fulfilling pharmaceutical supply requirements for federal military and healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 7/14/25 |